Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peptidylarginine Deiminase 2 in Host Immunity: Current Insights and Perspectives

4 Nov 2021

Abstract excerpt

Peptidylarginine deiminases (PADs) are a group of enzymes that catalyze post-translational modifications of proteins by converting arginine residues into citrullines. Among the five members of the PAD family, PAD2 and PAD4 are the most frequently studied because of their abundant expression in immune cells. An increasing number of studies have identified PAD2 as an essential factor in the pathogenesis of many...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Adhesion Molecules Research
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Share to Protease and Inhibitor Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34804050
DOI: 10.3389/fimmu.2021.761946

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peptidylarginine Deiminase 2 in Host Immunity: Current Insights and PerspectivesPMID 34804050Read ↗

PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritisSemantic proximity Read ↗

PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.Semantic proximity Read ↗

Peptidyl Arginine Deiminases in Chronic Diseases: A Focus on Rheumatoid Arthritis and Interstitial Lung DiseaseSemantic proximity Read ↗

PAD Inhibitors as a Potential Treatment for SARS-CoV-2 ImmunothrombosisSemantic proximity Read ↗

Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages.Semantic proximity Read ↗

PAD, a growing family of citrullinating enzymes: genes, features and involvement in diseaseSemantic proximity Read ↗

Targeting epigenetic and post-translational modifications regulating pyroptosis for the treatment of inflammatory diseasesSemantic proximity Read ↗

Role for Peptidylarginine Deiminase Enzymes in Disease and Female ReproductionSemantic proximity Read ↗

Role of citrullination modification catalyzed by peptidylarginine deiminase 4 in gene transcriptional regulationSemantic proximity Read ↗

An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory ProcessesSemantic proximity Read ↗

An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders.Semantic proximity Read ↗

Peptidylarginine deiminase 4 and citrullination in health and disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.